AI-generated summary
This review describes photodynamic therapy in dermatology, which uses a photosensitizer activated by light to destroy targeted cells. The authors report that topical 5-aminolevulinic acid or 5-methyl aminolevulinate PDT is very effective for actinic keratoses, basal cell carcinomas and Bowen's disease, and describe promising results in morphea, sarcoidosis, warts and photoaging. The abstract does not report sample sizes or formal outcome data.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes a narrative review and reports no pooled data, sample sizes or certainty ratings for the promising non-oncologic results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.